Li‐Xuan Qin

机构：Memorial Sloan Kettering Cancer Center, Kettering University · ORCID：0000-0002-9367-3807

发表论文 468 篇 · 总被引 10131 次 · h-index 51

代表论文

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma (2025 · ESMO Open · 被引 8)
Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear (2025 · Journal of Clinical Oncology · 被引 7)
Accuracy of Flexible Sigmoidoscopy and MRI in Restaging Rectal Cancer after Neoadjuvant Therapy (2025 · Annals of Surgery · 被引 4)
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 4)
Challenges and Opportunities for Statistics in the Era of Data Science (2025 · Harvard Data Science Review · 被引 4)
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor (2025 · Clinical Cancer Research · 被引 3)